Today’s healthcare industry is subject to a myriad of complicated and ever changing federal and state regulations. King & Spalding’s Healthcare Private Equity Practice lawyers have extensive experience in representing private equity funds, private equity management groups, and other institutional investors in transactions in the healthcare industry. Our Healthcare Practice assists these clients in structuring, negotiating and executing leveraged acquisitions and venture capital and growth financings and in dispositions of investments through sales, public offerings and recapitalizations.

Our significant depth of knowledge of the regulatory environment of the healthcare industry enables us to bring unique sophistication and insights to the due diligence process.  We also counsel private equity buyers regarding the complex laws and regulations applicable to healthcare providers participating in the federal health care programs and other players in the healthcare industry. This facilitates private equity buyers’ analysis of investment risks and potentials when considering and participating in transactions.

Much of the healthcare regulatory scheme applicable to the healthcare industry varies from state to state. Our Healthcare Industry Group has experience in representing private equity firms in transactions in states throughout the United States. Approximately 20 attorneys with substantial experience practice in our firm’s Healthcare Private Equity Practice.

Practice Recognitions:

• Two of the attorneys in this area have been recognized as top healthcare and transactional attorneys by Chambers USA.
  
  
• Two of the attorneys in this area have been recognized as Outstanding Healthcare Lawyers by Nightingale’s Healthcare News.